Moderna, Inc. (MRNA)

Moderna Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,772	16,001	37,919	69,006	102,976	41,340
Market Cap Growth	-40.60%	-57.80%	-45.05%	-32.99%	149.10%	534.21%
Enterprise Value	3,859	8,154	26,528	53,264	94,653	38,276
Last Close Price	25.01	41.58	99.45	179.62	253.98	104.47
PE Ratio	-	-	-	8.25	8.44	-
Forward PE	-	-	-	37.04	8.08	15.24
PS Ratio	4.34	4.95	5.54	3.58	5.58	51.48
PB Ratio	1.05	1.47	2.74	3.61	7.28	16.14
P/TBV Ratio	1.06	1.48	2.76	3.61	7.28	16.14
P/FCF Ratio	-	-	-	15.06	7.72	21.10
P/OCF Ratio	-	-	-	13.85	7.56	20.40
EV/Sales Ratio	1.73	2.52	3.87	2.77	5.12	47.67
EV/EBITDA Ratio	-	-	-	5.45	7.00	-
EV/EBIT Ratio	-	-	-	5.65	7.12	-
EV/FCF Ratio	-	-	-	11.63	7.10	19.54
Debt / Equity Ratio	0.08	0.07	0.09	0.06	0.07	0.09
Debt / EBITDA Ratio	-	-	-	0.12	0.07	-
Debt / FCF Ratio	-	-	-	0.26	0.07	0.12
Asset Turnover	0.16	0.20	0.31	0.76	1.15	0.18
Inventory Turnover	15.39	37.66	13.92	6.02	5.19	-
Quick Ratio	3.51	3.45	3.21	2.35	1.54	1.37
Current Ratio	3.93	3.67	3.43	2.73	1.76	1.44
Return on Equity (ROE)	-29.32%	-28.77%	-28.59%	50.27%	146.08%	-39.99%
Return on Assets (ROA)	-15.49%	-15.14%	-11.96%	23.30%	51.93%	-10.68%
Return on Capital (ROIC)	-18.54%	-18.44%	-14.96%	33.28%	93.06%	-23.21%
Return on Capital Employed (ROCE)	-33.10%	-33.10%	-27.50%	45.00%	85.60%	-25.90%
Earnings Yield	-31.89%	-22.25%	-12.43%	12.12%	11.85%	-1.81%
FCF Yield	-27.15%	-25.34%	-10.09%	6.64%	12.95%	4.74%
Buyback Yield / Dilution	-1.31%	-0.52%	8.17%	3.48%	-13.12%	-15.11%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q